Invetx
IPO, $80M+

A veterinary therapeutics company focused on biopharmaceuticals that bring the best of human biotechnology to animal health, Invetx came to MBI in 2021 with a team of 2 to start their first R&D lab. Invetx graduated from MBI in 2022 having built a team of over 12 employees, is now located in Boston, and has raised $80M+.

WordPress Lightbox